Is American Oncology Network (AONC) Fully Valued Following Cencora's $2.4b Buyout Deal?

Cencora (COR) has moved to take control of American Oncology Network (OTCPK:AONC) by signing a deal to acquire the remaining 96% it does not own for an enterprise value of $2.4b. American Oncology Network’s share price has surged in recent weeks, with a 7 day and 30 day share price return of about 100% and a 1 year total shareholder return of 149.26%. This suggests the Cencora offer has sharply reset expectations around the stock’s value and risk profile. Spot similar healthcare momentum by...